Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Total Assets

Adverum Biotechnlgs Total Assets Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Total Assets from 2013 to 2020.
  • Adverum Biotechnlgs Total Assets for the quarter ending June 06, 2020 was $331m a 37.94% increase of 126m year over year
  • Adverum Biotechnlgs Total Assets for the last 12 months ending June 06, 2020 was $331m a 37.94% increase of 126m year over year
  • Adverum Biotechnlgs Annual Total Assets for 2019 was $223m a 4.14% increase of 9m from 2018
  • Adverum Biotechnlgs Annual Total Assets for 2018 was $213m a 5.43% increase of 12m from 2017
  • Adverum Biotechnlgs Annual Total Assets for 2017 was $202m a -16.18% decrease of -33m from 2016
Other Balance Sheet Metrics:
  • Adverum Biotechnlgs Other Liabilities for the quarter ending December 12, 2018 was $2m a -14.42% decrease of 0m year over year
  • Adverum Biotechnlgs Total Equity for the quarter ending September 09, 2018 was $216m a 14.63% increase of 32m year over year
View Chart On Koyfin

Quarterly ADVM Total Assets Data

06/2020$331m
03/2020$349m
12/2019$223m
09/2019$206m
06/2019$210m
03/2019$221m
12/2018$213m
09/2018$226m
06/2018$247m
03/2018$257m

Annual ADVM Total Assets Data

2019$223m
2018$213m
2017$202m
2016$235m
2015$264m
2014$162m
2013$1m
2012$0m